Últimas noticias sobre OSR Holdings (NASDAQ:OSRH) Bolsa

OSR Holdings

OSR Holdings Inc is a healthcare company, dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of and potentially transformative therapies and healthcare solutions.

OSR Holdings Inc

William Blair analyst Cristopher Kennedy upgrades Nayax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) from Market Perform to Outperform.

News

Upgrades

Analyst Ratings

NYAX

William Blair Upgrades Nayax to Outperform

<a href="https://corp.roblox.com/newsroom/2025/04/roblox-scales-video-ads-partners-with-google" title="https://corp.roblox.com/newsroom/2025/04/roblox-scales-video-ads-partners-with-google">https://corp.roblox.com/newsroom/2025/04/roblox-scales-video-ads-partners-with-google</a>

GOOG

GOOGL

RBLX

'Roblox Launches Rewarded Video Ads, Partners With Google To Scale Immersive Advertising' - Roblox

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.97</td>
<td align="right">0.12</td>
<td align="right">0.28</td>
<td>1.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">78.94</td>
<td align="right">0.09</td>
<td align="right">0.11</td>
<td>7.2K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">145.4300</td>
<td align="right">-0.580</td>
<td align="right">-0.40</td>
<td>5.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">205.7700</td>
<td align="right">-0.710</td>
<td align="right">-0.35</td>
<td>84.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">49.6785</td>
<td align="right">-0.132</td>
<td align="right">-0.27</td>
<td>260.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">93.2100</td>
<td align="right">-0.240</td>
<td align="right">-0.26</td>
<td>29.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.6600</td>
<td align="right">-0.010</td>
<td align="right">-0.02</td>
<td>12.8K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Leading And Lagging Sectors For April 1, 2025

<a href="https://www.jacobs.com/newsroom/news/jacobs-tackle-wastewater-treatment-emissions-alongside-metro-vancouver" title="https://www.jacobs.com/newsroom/news/jacobs-tackle-wastewater-treatment-emissions-alongside-metro-vancouver">https://www.jacobs.com/newsroom/news/jacobs-tackle-wastewater-treatment-emissions-alongside-metro-vancouver</a>

Contracts

'Jacobs to Tackle Wastewater Treatment Emissions Alongside Metro Vancouver' - Jacobs

UBS analyst Neal Burk upgrades ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>) from Neutral to Buy and raises the price target from $123 to $147.

Price Target

ESAB

UBS Upgrades ESAB to Buy, Raises Price Target to $147

Offerings

CTXR

Citius Pharmaceuticals Announces $2M Registered Direct Offering oO  1.739M Shares At $1.15/Share

General

NTRP

NextTrip Sees Strong Growth in Group Bookings After Partnering with Five Star Alliance

Earnings

POLA

Polar Power Q4 EPS $(1.22) Up From $(1.66) YoY; Revenue $2.622M Down From $3.605M YoY

Truist Securities analyst Ki Bin Kim maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Hold and lowers the price target from $23 to $19.

Truist Securities Maintains Hold on Macerich, Lowers Price Target to $19

&nbsp;GRI Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRI#NASDAQ">GRI</a>) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today reported interim safety results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis ("IPF"). &nbsp;
The pre-planned interim analysis for 2-week safety results from the ongoing Phase 2a biomarker study demonstrated GRI-0621 (4.5mg orally once daily) to be safe and well-tolerated in the first 12 patients evaluated per protocol. Hyperlipidemia, as assessed by LDL, HDL and triglyceride (TG) levels, was not seen in the 12 patients assessed at the 2-week visit. There ere no meaningful changes in HDL, LDL or TG levels in patients receiving GRI-0621, and all subjects remained within normal ranges. The interim analysis committee recommended the study should continue as planned. The interim results show that GRI-0621's receptor selectivity is consistent with the toxicity profile observed in earlier studies evaluating oral tazarotene in over 1,700 patients treated for up to 52 weeks. &nbsp;

ALPS ETF Trusthen & Steers Global Realty Majors ETF

GRI Bio Reported Interim 2-Week Safety Results From Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis

Biotech

IGC Pharma Expands CALMA Phase 2 Trial with Miami Jewish Health Addition

In the face of escalating protests and boycotts,&nbsp;Errol Musk, father of Elon Musk, has come forward to defend his son&#8217;s cost-cutting initiatives for the U.S. government and his EV company &nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
What Happened: Errol has responded to the growing backlash from U.S. taxpayers and Tesla customers against Elon Musk&#8217;s role in the Department of Government Efficiency (DOGE), a body established by the Trump administration. The electric vehicle manufacturer, Tesla, has been dealing with sales boycotts and protests, with several US dealerships reporting vandalized and burnt vehicles.
Errol Musk, while speaking to Darren McCaffrey on Sky News on Monday, dismissed the protesters as &#8220;bums&#8221; attempting to harm Tesla by damaging cars, calling it &#8220;plain silly.&#8221; He attributed the anger towards Elon Musk to &#8220;media hype&#8221; and brushed off concerns among Tesla investors about the company&#8217;s challenges amidst the protests.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Elon Musk&#039;s father speaks out on son&#039;s controversial Tesla and DOGE decisions" width="500" height="281" src="https://www.youtube.com/embed/ArwQdZwFKJ4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/25/04/44579813/bill-gates-declares-that-his-children-would-inherit-less-than-1-of-his-fortune-i-am-not-asking-them-to-run-micros" target="_blank" rel="noreferrer noopener">Bill Gates Says His Children Would Inherit Less Than 1% Of His Fortune: &#8216;I Am Not Asking Them To Run Microsoft&#8217;</a>
He also refuted any suggestions that his son was overstretched, stating that there were competent people at Tesla to handle day-to-day business while Elon focused on &#8220;vital work&#8221; for U.S. taxpayers. Regarding Elon Musk&#8217;s role in DOGE, father Musk stated that Elon is &#8220;doing the right thing&#8221; by &#8220;cleaning up the mess.&#8221;
Elon Musk&#8217;s father attributed the decline in Tesla&#8217;s share price to overall market sentiment and not particularly the EV maker. He assured that Tesla shares, currently trading at $254,&nbsp;would recover to $600 per&nbsp;share by the end of the year. 
Why It Matters: Earlier this month, Errol Musk warned in an interview with&nbsp;<a href="https://www.benzinga.com/news/25/03/44283540/elon-musks-father-warned-in-november-that-if-elon-had-to-step-away-from-his-companies-for-government-duties-it-could-be-a-big-concern">Al Arabiya News</a>&nbsp;about the potential implications if Elon Musk had to step away from his companies for government duties. He expressed that it would be a "big concern" if Elon had to step away from board meetings and company leadership.
Despite the ongoing protests and vandalism targeting Tesla, Errol views these incidents as beneficial for the company. In a recent interview on "The Andrew Eborn Show," he <a href="https://www.benzinga.com/news/25/03/44550251/elon-musks-father-says-tesla-vandalism-and-protests-are-just-free-publicity-claims-all-the-stocks-have-come-down-not-just-tesla">dismissed the backlash</a> as good for business, stating, "Publicity. More publicity, free publicity.&#8221;
Tesla stock lost 1.67% to close at $259.16 on Monday. Over the past 30 days, the stock declined nearly 9%.
Tesla holds a momentum rating of 90.20% and a growth rating of 67.66%, according to <a href="https://www.benzinga.com/quote/TSLA" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s Proprietary Edge Rankings</a>. For an in-depth report on more stocks and insights into growth opportunities, <a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a> <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01085921/Screenshot-2025-04-01-at-6.29.11%E2%80%AFPM-1024x163.png" alt="" class="wp-image-851179" /></a></figure>
Tesla consensus price target stands at $309.55, based on ratings from 29 analysts, with a high of $550 from Wedbush on March 27 and a low of $24.86 from GLJ Research on Feb. 12. The latest ratings from Stifel, Deutsche Bank, and Wedbush, issued on March 31, 28, and 27, respectively, average a $450 price target. This suggests a potential 70.95% upside for Tesla based on these recent analyst projections, according to data from <a href="http://pro.benzinga.com">Benzinga Pro.</a>
<ul>
<li>Read Next: <a href="https://benzinga.com/25/03/44570246/whats-going-on-with-lucid-stock-today" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Lucid Stock Today? </a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

LCID

TSLA

Elon Musk's Father Defends Tesla, Says Son Is 'Doing The Right Thing' And The Stock Would Recover To $600 By 2025 End: Here's What Analysts Think About TSLA

Earnings Misses

LPRO

CORRECTION: Open Lending Q4 GAAP EPS $(1.21) Misses $0.02 Estimate, Sales $(56.92M) Miss $23.65M Estimate

Truist Securities analyst Ki Bin Kim maintains Acadia Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKR#NYSE">AKR</a>) with a Hold and lowers the price target from $25 to $23.

Truist Securities Maintains Hold on Acadia Realty Trust, Lowers Price Target to $23

WIIM

CMPX

Compass Therapeutics shares are trading higher after the company announced updates and top-line data for COMPANION-002.

Truist Securities analyst Barry Jonas maintains Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) with a Buy and lowers the price target from $92 to $85.

Truist Securities Maintains Buy on Boyd Gaming, Lowers Price Target to $85

Management

Macy's Names Thomas J. Edwards Chief Operating Officer And Chief Financial Officer, Effective June 22nd

CPRI

Capri Holdings COO And CFO Thomas Edwards To Resin; Rajal Mehta To Be Interim CFO

Truist Securities analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) with a Buy and lowers the price target from $11 to $10.

AUTL

Truist Securities Maintains Buy on Autolus Therapeutics, Lowers Price Target to $10

Asset Sales

LegalZoom Announces Sale of Austin, Texas Facility For ~$38M In Cash

Press Releases

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment

Comments

OSR Holdings

Noticias

Últimas noticias sobre OSR Holdings (NASDAQ:OSRH) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL